EuropaBio
Non-profit Organisaties in de buurt
1000
Avenue des Arts, 56
Rue Montoyer
1000
Rue Belliard
Rue Belliard
Goethe-Institut Brüssel
Rue Belliard
Rue du Commerce
Avenue des Arts
As the European Association for Bioindustries, we showcase the benefits and value of an innovative biotech sector in Europe. Engage with us #biotech4life
EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy.
21/12/2022
🟣 With the right policies and incentives in place, has the possibility to capitalise on the resources of twenty-seven Member States and break the barriers to growth for established , , and developing orphan medicinal products ( ).
🟣 The revision of the is an opportunity to build on past successes and enable Europe to become a leading region for innovation in the decades to come.
🟣 Read the blog post by Dr. Claire Skentelbery: 👉 https://bit.ly/3Eotcvb.
🟣
The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it? Europe’s complex rare disease ecosystem relies primarily on a fragile complementary relationship between academia, start-ups, and well-established companies to bring scientific and technological progress. The recent publication of draft impact assessment by Politico Europe renewed concerns that th...
20/12/2022
🟣 The has already delivered for but more can be done. 👇
🟣
📌
19/12/2022
🟣 The European Union continues to grow as a region of healthcare excellence.
🟣 Creating an environment to attract, maintain, and increase investments in innovative biotech discoveries will ensure that the EU is the world’s most advanced region for both public and private biotech and .
🟣 EuropaBio’s vision: a Europe where delivers benefits across society, from high-skill jobs and economic strength to ground-breaking treatments that change and save lives.
🟣 Watch the video to learn more! 👇
📌
Europabio - Healthcare Biotech (Subtitled) This is "Europabio - Healthcare Biotech (Subtitled)" by Cartoonbase on Vimeo, the home for high quality videos and the people who love them.
🟣 To support the uptake of , EuropaBio proposes a set of 12 policy and associated , including 3 propositions related to and . 👇
🟣
📌 https://bit.ly/3Po2JS8
15/12/2022
🎤 We sat down with our new member SenseUP Biotechnology, to find out more about the natural evolution approach for novel and products. 🔎
📰 Read the interview with Dr. Georg Schaumann, CEO and Founder: 👉 https://bit.ly/3WfNjl2.
🟣 Increased access to genetic testing is a significant opportunity for and systems in by supporting the deployment of targeted therapeutic strategies.
🟣 But investments in are essential to make testing more widely available to support the broader needs of the population.
🟣 To support the uptake of , EuropaBio proposes a set of 12 policy and associated , including 3 propositions concerning and . 👇
🟣
📌 https://bit.ly/3Po2JS8
14/12/2022
📢 We are pleased to announce that the German natural evolution company has joined as an associate member! 🤝
🧬 After starting as a spin-off from the Institute for at Forschungszentrum Jülich and undertaking years of systematic technology development, is now working with global players from the , and industries to develop superior production processes. ⚙️
📌 Read the press release: 👉
SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions Brussels, 13 December 2022 – EuropaBio is pleased to announce that the German natural evolution company SenseUp has joined as an associate member.
🟣 and (non-genetic) tests for genetic risk factors are medical tests used to identify in genes that correlate to a ’s risk of developing a certain .
🟣 Increased access to genetic testing is a significant opportunity for and systems in by supporting the deployment of targeted therapeutic strategies.
🟣 To support the uptake of , EuropaBio proposes a set of 12 policy and associated , including 3 propositions concerning and . 👇
🟣
📌 https://bit.ly/3Po2JS8
🟣 Advances in science and technology have greatly improved our understanding of the genetic basis of , which have made it possible to redefine many diseases at higher resolution and target them with more precise such as cell and .
🟣 Increased access to genetic testing is a significant opportunity for and systems in by supporting the deployment of targeted therapeutic strategies.
🟣 To support the uptake of , EuropaBio proposes a set of 12 policy and associated . Here are the first 3, about pathways. 👇
🟣
📌 https://bit.ly/3Po2JS8
🟣 development advances alone do not deliver products to patients. The development pathway requires diverse skills to enable to succeed in delivering treatment solutions.
🟣 One of the most significant bottlenecks for SME and technology maturation is access to professional . This experience gap can only be addressed in the short term by greater public and private with practices and information sharing
🟣 Read our recommendations in the Report: 👉 https://bit.ly/3F4RitS, and register to our Webinar, next week: 👉 https://bit.ly/3haNyiq.
🟣
🟣 For European ’ growth and survival, it is fundamental to achieve more regulatory across Europe to ensure that find their market with appropriate pricing and reimbursement decisions and that are available to .
🟣 Read our recommendations in the Report: 👉 https://bit.ly/3F4RitS, and register to our Webinar, next week: 👉 https://bit.ly/3haNyiq.
🟣
🟣 The development field is recent and fast-evolving. While technology progresses rapidly, national regulators must learn and adapt quickly to support the development and approval of new cell and .
🟣 The European Medicines Agency (EMA) and the EU regulatory network have to deliver a streamlined, flexible and coherent regulatory system, with good coordination between the and the Member States, optimising support for new advances in innovation and accelerating .
🟣 Read our recommendations in the Report: 👉 https://bit.ly/3F4RitS, and register to our Webinar, next week: 👉 https://bit.ly/3haNyiq.
🟣
🟣 Last May, the European Commission published the first evaluation of the Directive, more than ten years after its adoption.
🟣 The evaluation highlighted the many issues surrounding the Directive as well as the many that seeking across borders face. Read our to improve cross-border healthcare in Europe. 👇
🟣
📌 https://bit.ly/3VfavQp
30/11/2022
Today, we officially launched EuropaBio's (https://bit.ly/3XEeuHU), with a roundtable focused on the role and potential of enabling technologies in the .
Policy makers, Member States representatives and other stakeholders joined members to drive the discussion, which ended with three industry asks for 2023 and beyond: ⬇️
1. Modernizing regulation and policy: enabling impact
2. Education and awareness: enabling citizens
3. Financing innovation: enabling technologies
📌 Read the full press release: ➡️ https://bit.ly/3GYsoyM.
🟣 Cross-border healthcare for in requires significant planning from and their carers to deal with complex administrative procedures which can vary from one country to the next.
🟣 Better to ATMPs in Europe is dependent on a well-functioning cross-border framework. Read our recommendations. 👇
🟣
📌 https://bit.ly/3VfavQp
🟣 For patients whose treatment involves , cross-border is often the only way to access these transformative .
🟣 considers that the evaluation of the Directive is a first step in a larger review process of the cross-border healthcare framework to improve access. Read our position. 👇
🟣
📌 https://bit.ly/3VfavQp
24/11/2022
🟣 The EU’s Blood, Tissues, and Cells ( ) legislation is a central piece of the puzzle to ensure the uptake of transformative advanced which hold great potential for both the and well-being of , as well as the of systems.
🟣 Establishing a predictable, future-proof, and fair BTC framework is critical for the sector, as requirements for , , and apply to , , and used in the production of ATMPs.
🟣 Read our Statement: 👉 https://bit.ly/3DRV1dO, and our Response to the Consultation: 👉 https://bit.ly/3NVB0HW.
🟣
🟣 considers the proposal of a Regulation on to be an opportunity for convergence of requirements across Member States and ensure that regulatory standards protecting safety and public keep pace with technical and scientific .
🟣 Read our recommendations to ensure the can support developers in Europe. 👇
🟣
📌 https://bit.ly/3NVB0HW
🟣 As the European Association of innovative and companies representing developers of cell-based and plasma-derived medicines, is committed to supporting patient access to essential and innovative and to becoming a global leader in innovation.
🟣 This is why we consider the adoption of the proposal for a Regulation on revising the EU’s Blood, Tissues, and Cells ( ) legislation as an opportunity to ensure regulatory standards protecting patient safety and public keep pace with technical and scientific advances.
🟣
📌 https://bit.ly/3DRV1dO
18/11/2022
🟣 The ( ) proposal is the cornerstone of future European policy and is critical to ensuring that have access to, and control of their data.
🟣 calls for a multi-stakeholder approach in shaping Europe’s digital transition to ensure citizens' trust and understanding of the benefits accessible has for society.
🟣 Read our position paper: 👉 https://bit.ly/3JbgvEH, and our dedicated factsheet: 👉 https://bit.ly/3SCicxZ.
🟣
🟣 The marks a global first in providing federated access to important . Placing a central focus on citizens’ control over their data, the seeks to implement a framework through which data access for primary and secondary use is both clarified and simplified.
🟣 Here are our core , reflecting on the EHDS legislative proposal, for the use of data in the development of novel derived medicines: 👇
🟣
📌https://bit.ly/3OcyP2x
📌https://bit.ly/3X9wdqg
🟣 What do you think is the most important use of in ? 👇
🟣 Let us know through this : 👉 https://bit.ly/3GmKB8C, and read more about our position on the here: 👉 https://bit.ly/3E8qeJR.
🟣
🟣 The revision of the Regulation is the perfect opportunity to establish a regulatory system fit for the 21st Century. 👇
🟣
📌 https://bit.ly/3U13DFy
🟣 The revision of the Regulation should continue to guarantee the predictability of to accelerate innovation for . 👇
🟣
📌 https://bit.ly/3U13DFy
Klik hier om uitgelicht te worden.
Video's (alles zien)
Telefoon
Website
Adres
Avenue Des Arts 53
Brussels
1000
Openingstijden
| Maandag | 09:00 - 18:00 |
| Dinsdag | 09:00 - 18:00 |
| Woensdag | 09:00 - 18:00 |
| Donderdag | 09:00 - 18:00 |
| Vrijdag | 09:00 - 18:00 |
European Students' Union - ESU
Mundo-Madou. Avenue Des Arts 7/8
Brussels, 1000
🔵 ESU is the umbrella organisation of 44 National Unions of Students from 40 European countries. 🟢 Fighting for students' rights since 1982 💪🏻 linktr.ee/europeanstudents
Forum of Azerbaijani Students in Europe
Brussels, B-1050
FASE was formed in 2006 and held a number of forums in Brussels, Berlin, London and Paris with the aim of uniting Azerbaijani students.
JM International
Square Eugène Plasky 92-94, Box 13
Brussels, 1030
JMI is a global nonprofit that provides opportunities for young people and children to develop through music across all boundaries.
UNICEF Belgium
Picardstraat 7/306
Brussels, 1000
PAGE OFFICIELLE DE L'UNICEF BELGIQUE OFFICIËLE PAGINA VAN UNICEF BELGIË
Philea
Rue Royale 94
Brussels, 1000
We are the voice of European philanthropy. Our purpose is to harness its immense multidimensional potential.
Association of European Cancer Leagues
Chaussée De Louvain 479
Brussels, 1030
ECL is an European umbrella organisation of cancer leagues around Europe. Support our efforts in "Making a Difference in Cancer Prevention and Control!" http://www.europeancancerle...
De Wakkere Burger vzw
Priemstraat 51
Brussels, 1000
De Wakkere Burger vzw is een sociaal-culturele beweging die zich inzet voor burgerparticipatie en democratie.
Inclusion Europe
Avenue Des Arts 3
Brussels, 1210
Ambitions. Rights. Belonging. 20 million people with intellectual disabilities and their families from 39 European countries.
European Rail Infrastructure Managers
Square De Meeûs 1
Brussels, B-1000
EIM is promoting the interests of the independent rail Infrastructure Managers in Europe. Our goal is open, seamless, safe and sustainable European rail network.
ECYC - European Confederation of Youth Clubs
Rue D'Edimbourg 26, Ixelles
Brussels, 1050
Together for open youth work in Europe!
YSAFE
55 Rue Royale
Brussels, 1000
YSAFE is a youth network of volunteers within Sexual and Reproductive Health and Rights active in Eur
International Federation for Spina Bifida and Hydrocephalus
Rue Des Alexiens 16
Brussels, 1000
The International Federation for Spina Bifida and Hydrocephalus (IF) is the umbrella organisation for Spina Bifida and Hydrocephalus associations worldwide.